» Articles » PMID: 28360583

The Use of Complementary and Alternative Medicine in Patients with Migraine

Overview
Date 2017 Apr 1
PMID 28360583
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Although many patients with migraine get positive benefits from conventional pharmacological treatments, many others do not benefit sufficiently or experience adverse effects from these treatments. For that reason, these patients usually seek complementary and/or alternative medical (CAM) treatments all over the world. In general, although CAM therapies are not recommended by neurologist in Turkey, most of migraine patients, who do not respond conventional medicine treatments, seek alternative therapy. Acupuncture, botulinum toxin, mind-body interventions, and nutraceutical options are the most popular treatments. In this review, the available evidence for all these treatments will be discussed.

Citing Articles

Evaluation of clinical characters and use of alternative medicines in the management of headache and predictors of treatment satisfaction among Saudi adults - A community-based study in Saudi Arabia.

Alghamdi A, Eidhah Alsufyani M, Ali Alwadei F, Abdullah Alshehri H, Samarkandi O, Syed W Prev Med Rep. 2024; 43:102787.

PMID: 38975282 PMC: 11225024. DOI: 10.1016/j.pmedr.2024.102787.


Complementary and alternative medicine use in migraine patients: results from a national patient e-survey.

Makarevicius G, Dapkute A, Ryliskiene K Front Neurol. 2024; 15:1378532.

PMID: 38863511 PMC: 11165229. DOI: 10.3389/fneur.2024.1378532.


Preliminary efficacy of aerobic training among university students with migraine symptoms: Study protocol for a pilot randomized controlled trial.

Selvakumar K, Lee Fan T, Chai Nien F, Hou Kit M PLoS One. 2023; 18(9):e0291534.

PMID: 37747888 PMC: 10519594. DOI: 10.1371/journal.pone.0291534.


Ayurveda for management of migraine: A narrative review of clinical evidence.

Soman A, Venkatram S, Chikkanna U, Ramakrishna K, Bhargav H, Mailankody P J Family Med Prim Care. 2022; 11(8):4228-4235.

PMID: 36352975 PMC: 9638656. DOI: 10.4103/jfmpc.jfmpc_2109_21.


Neurogenic Inflammation: The Participant in Migraine and Recent Advancements in Translational Research.

Spekker E, Tanaka M, Szabo A, Vecsei L Biomedicines. 2022; 10(1).

PMID: 35052756 PMC: 8773152. DOI: 10.3390/biomedicines10010076.


References
1.
Lipton R, Varon S, Grosberg B, McAllister P, Freitag F, Aurora S . OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology. 2011; 77(15):1465-72. DOI: 10.1212/WNL.0b013e318232ab65. View

2.
Hershey A, Powers S, Vockell A, LeCates S, Ellinor P, Segers A . Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007; 47(1):73-80. DOI: 10.1111/j.1526-4610.2007.00652.x. View

3.
Rabinstein A, Shulman L . Acupuncture in clinical neurology. Neurologist. 2003; 9(3):137-48. DOI: 10.1097/00127893-200305000-00002. View

4.
Unsal A, Gozum S . Use of complementary and alternative medicine by patients with arthritis. J Clin Nurs. 2010; 19(7-8):1129-38. DOI: 10.1111/j.1365-2702.2009.03111.x. View

5.
Hu X, Markson L, Lipton R, Stewart W, Berger M . Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999; 159(8):813-8. DOI: 10.1001/archinte.159.8.813. View